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Summary.-A calcitonin-responsive adenylate cyclase has been found in a cell line of
a poorly differentiated bronchial carcinoma (BEN cells). The cells have previously
been shown to secrete an immunoreactive form of calcitonin in culture. Salmon
calcitonin (SCT), porcine calcitonin (PCT) and human calcitonin (CT-M) all stimu-
lated adenylate cyclase activity in particulate preparations. CT-M sulphoxide had
little effect. The concentrations of the calcitonins required for half the maximum
activation of adenylate cyclase were 6-8, 18 and 90 nM respectively. SCT (30 pM) and
CT-M (60 pM) increased the intracellular concentration of cyclic AMP from 11.2+0-2
(s.e.) to 18-2 + 0-2 and 16-7 ± 0-2 respectively over a 2*5-min period.
SCT (labelled with 1251) bound to particulate preparations of BEN cells, and com-
petition for binding occurred with unlabelled SCT and CT-M. The concentration of
SCT required for half the maximum inhibition of[125I]SCT binding was 11 nm. CT-M
sulphoxide inhibited only at high concentration (3Mm).
The characteristics of the adenylate cyclase response to SCT did not change over
the period between cell adhesion (after subculture) and confluence. However, pre-
incubation of cells for 4 h with SCT (150 nM) abolished the subsequent adenylate
cyclase response of particulate preparations to further hormone. The practical dif-
ficulties encountered in purifying and quantifying the large-mol.-wt. form of CT-M
secreted by BEN cells has precluded direct investigation of the potential relationship
between hormone secretion and the occurrence of the calcitonin receptor. This re-
lationship is discussed in terms of its possible biological significance.
THE development of neoplasia in
animal tissues is associated with striking
changes in cell function. Release of
" foetal reversion products ", such as
carcinoembryonic antigen (CEA) and o-
foetoprotein (Neville and Cooper, 1976)
and ectopic hormone production (Rees and
Ratcliffe, 1974) are common examples.
Other phenomena which have been ob-
served are changes in the number or type
of hormone receptors at the cell surface
(Schorr et al., 1971; Christoffersen et al.,
1972; Christoffersen et al., 1974; Boyd,
Louis and Martin, 1974; Christoffersen
and Berg, 1975) and alterations in the
metabolism of cyclic nucleotides (Clark,
Reprint requests to Professor T. J. Martin.
Morris and Weber, 1973; Minton, Wisen-
baugh and Matthews, 1974; Ryan and
Heidrick, 1974; DeRubertis, Chayoth and
Field, 1976). In reviewing evidence in the
latter field, it was apparent that intra-
cellular cyclic adenosine 3',5'-monophos-
phate (cyclic AMP) levels could not be
regarded as having a simple negative
correlation with growth, particularly in
view ofthe fact that some tumours in vivo
had high levels of cyclic AMP (Minton
et al., 1974) and of adenylate cyclase
(Martin et al., 1976). This led to the
view that the regulation of intracellular
cyclic AMP levels might be less important
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certain metabolic functions of cancer cells.
The present experiments arose out of
studies of hormone-responsive adenylate
cyclase in cancer cells possessing the
particular function of " inappropriate "
hormone production (Martin et al., 1976).
A human cancer cell line which contin-
uously secreted a large-mol.-wt form of
human calcitonin (Ellison et al., 1975,
1976a; Coombes et al., 1976, 1977) was
found to contain an adenylate cyclase
which responded to biologically active
calcitonin. The present report describes
some properties ofthehormone-responsive
adenylate cyclaseanddemonstratesspecific
binding of labelled calcitonin to parti-
culate fractions of the cells. Some
evidence is alsopresented bearing upon the
biologicalactivityofthe secreted calcitonin
and the relationship to the " feedback"
control which is apparent in culture.
METHODS
Cell culture.-An epithelial cell line (BEN)
was established from a poorly differentiated
epidermoid bronchial carcinoma, as
described previously (Ellison et al., 1975).
Cells were cultured in 45% TC199 HEPES
buffered medium (Biocult) plus 45%
Dulbecco's Eagle's bicarbonate-buffered
medium, plus 10% outdated human
plasma in 25-cm2 plastic Falcon flasks.
100 ug/ml kanamycin and 25 ,ug/ml ampho-
tericin B were added to themedium. Cultures
were gassed (5% CO2 in air) and maintained
at 37°C. Cells were subcultured each week.
They have continued to secrete CEA and
calcitonin since the earlier report (Ellison et
al., 1975).
Hormones.-Synthetic salmon calcitonin
(SCT) lot No. K600128C-1, was a gift from
Dr J. W. Bastian, Armour Pharmaceutical
Co., Kankakee, Illinois, and human calcitonin
(CT-M) and CT-M sulphoxide were gifts from
Dr W. Rittel, CIBA, Basle, Switzerland.
Human growth hormone (Commonwealth
Serum Laboratories, Parkville, Australia) was
clinical-grade material, and ovine prolactin,
also partially purified, was a gift from Dr
C. J. Robinson, Dept. of Physiology, Uni-
versity of Newcastle upon Tyne. Prosta-
glandins were a gift from Dr John Pike,
Upjohn Co., Kalamazoo, Michigan, and
pentagastrin was obtained from I.C.I. Sources
of parathyroid hormone, histamine, vaso-
pressin, glucagon and isoprenaline were as
listed previously (Martin et al., 1976).
Adenylate cyclase activity.-Assays were
carried out when cell cultures were at or near
confluence, unless otherwise indicated.
Medium was decanted from the culture
flasks and the cells rinsed twice with 5 ml
0-154M NaCl. Cells were scraped from the
surface with a plastic " policeman " and
homogenized in an all-glass, hand-held homo-
genizer (6 strokes) in the buffer used for the
enzyme assay (25 mm Tris HCI, pH 7-8,
4.5 mM Mg2+, 30 mm K+). After centrifuga-
tion (2200 g for 10 min) the particulate pre-
paration was resuspended for assay. The
adenylate cyclase assay system has been
described previously (Hunt et al., 1976).
Briefly, [o-32P]ATP was incubated with
particulate preparations in a volume of
100 ,ul for 20 min at 30°C in the presence of
the necessary ions, an ATP-regenerating
system and 1 mm unlabelled cyclic AMP to
inhibit breakdown of labelled cyclic AMP.
The reaction was stopped by boiling, after
adding an excess of unlabelled ATP, and the
[32p] cyclic AMP was purified by sequential
chromatography on columns of Dowex and
alumina (Salomon, Londos and Rodbell,
1974). [3H]cyclic AMP added at the column
stage was used to monitor recoveries, which
were 75-85%. Protein concentrations were
measured by the method of Hartree (1972).
Cyclic AMP measurement.-Replicate
cultures were established in plastic Leighton-
type tubes. When the cultures had grown to
near confluence (approximately 3 x 106 cells
per tube) media were changed and a 30-min
equilibration period allowed, in medium
containing 01% bovine serum albumin
(Armour) and no plasma. To this medium
was added either hormone in 20 ,u 10 mM
acetic acid or acetic acid alone. Ten min later
the medium was decanted, the cells were
quickly rinsed twice with 3 ml cold 0.154m
saline, and 1 ml 50 mm NH40H was added to
remove the cells. After boiling for 5 min, the
residue was freeze-dried and reconstituted for
assay by the protein-binding method of
Brown et al. (1971). The overall procedure
was validated by (i) adding unlabelled
cyclic AMP to cell cultures and showing that
recovery was quantitive, and (ii) establishing
parallelism between serially diluted samples
and assay standards.CALCITONIN-RESPONSIVE ADENYLATE CYCLASE IN A CELL LINE
Calcitoninbinding.-Synthetic salmon cal-
citonin was labelled with 125I by the method
of Hunter and Greenwood (1962), using 2 jig
of chloramine T as oxidant. In the case of
SCT this has been shown to produce bio-
logically active labelled hormone (Marx,
Fedak and Aurbach, 1972; Sraer and
Ardaillou, 1973). After purification using
Quso G32 (Yalow and Berson, 1966) the
[125I]SCT was used for binding studies.
Specific activity was consistently between 80
and 120 p/Ci/mg. Incubations were carried
out at 25°C in plastic tubes (12 x 75 mm) in
a total volume of 200 IlI, consisting of 50 mM
Tris-HCl, pH 7*4, 2 g/100 ml bovine serum
albumin, 1 mm disodium EDTA. Tubes
contained 20,000 ct/min of [1251]SCT and
varying amounts of unlabelled SCT. After
preliminary experiments showed that binding
was maximal at 10 min, and began to decline
slowly at 20 min, incubation times of 15 min
were used. At the end of this period, 100 jlI
samples were removed from incubation
mixtures and layered on top of 200 ul of
10 g/100 ml sucrose in polypropylene tubes
and centrifuged at 10,000 g for 2 min in a
Beckman Microfuge. After aspirating the
supernatant, the tips ofthe tubes were cut off
and counted in a Packard Auto Gamma
counter.
RESULTS
When a number of hormones were
tested at high concentrations, the
adenylate cyclase of the BEN cell mem-
branes was activated by isoprenaline,
prolactin, human growth hormone, and
SCT (Table I). The greatest stimulation
was obtained with SCT and this was
always of greater magnitude than the
effect of fluoride. The effects of prolactin
and growth hormone were small but
reproducible, and were seen only at high
concentrations. Isoprenaline also con-
sistently caused a minor increase in
adenylate cyclase activity, but this was
not investigated in detail. When the
calcitonin response was examined further,
calcitonins of three species were found to
produce dose-dependent effects on adenyl-
ate cyclase at low hormone concentrations
(Fig. 1). Half-maximal activation of
adenylate cyclase by porcine, human and
salmon calcitonins was produced by con-
centrations of 18 nm, 90 nm and about
7 nm respectively. The sulphoxide form
of CT-M, which has little or no calcium-
lowering activity in the rat (Neher et al.,
1968),producedasmallactivationofadenyl-
ate cyclase at a concentration of 600 nM.
When intact cells were tested, both
SCT and CT-M increased the cellular
levels of cyclic AMP over a 2-5-min
period. Control cells contained 11-2 + 0-2
(s.e.) pmol cyclic AMP/tube, whereas
SCT (30 pM) increased the level to 18-2 i
0-2 pmol (P < 0*001) and CT-M (60 pM)
increased itto 16 7 ± 0.2 pmol (P < 0 001).
TABLE I. Effect of Hormones on Adenylate Cyclase Activity in Particulate Preparations
ofBEN Cells. PGE1 andPGE2,Prostaglandins E1 and E2;PTH,Parathyroid Hormone;
HGH, Human Growth Hormone; SCT, Salmon Calcitonin. Values are Means ± s.e.
from 3 Determinations
Treatment
Basal
PGE1 30 gM
PGE2 30,uM
PTH 2 pM
Histamine 500 Mm
Vasopressin 200 mU/ml
Gastrin 24 gM
Glucagon 6 /IM
HGH 80 gM
Prolactin 80 UM
Isoprenaline 200 Mu
SCT 3 uM
NaF 10 miM
Cyclic AMP generated
(pmol/mg
protein/20 min)
151±2
172± 14
141±17
162± 18
113±13
158±15
143± 17
155± 5
257± 16
232± 6
383+ ±13
832± 88
469±31
p
(Difference
from basal)
NS
NS
NS
NS
NS
NS
NS
<0-01
<0*001
<0-001
<0-001
<0-001
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FIG. I. Adenylate cyclase activity in particulate preparations of BE-N cells. Assay of acdenylate
cyclase activity was carried out, as described in Methods, in the presence of salmon calcitonini
(0 *), porcine calcitonin (0 O), human calcitonin (A A) or human calcitonin
sulphoxide ( C -). Basal (unstimulated) adenylate cyclase activity (......) was 41 ± 3
pmol cyclic AMP generated/mg protein/20 min. Values are means s.e. of 3 leterminations.
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FIG. 2.- Binding of calcitonin to BEN cell membranes. ['251]SCT was inctubatecd with membranes,
un(ler con(litions described in Methods, and bound separated fiom free labelled hormone after
15 min at 25°C. Competition for binding was tested writh unlabelledl salmon calcitonin (0), human calcitonin (0), anclhuman calcitonin sulphoxi(ie (A). Values are means s.e. of 3
dleterminations.
[1251]SCT bound to particulate pre-
parations of BEN cells, and competition
for binding was shown by unlabelled SCT
and, at higher concentrations, by CT-M
(Fig. 2). In much higher concentrations
(3/,tM), CT-M sulphoxide competed to
some extent for binding. The concentra-
tion of SCT required for half-maximal
inhibition of binding of labelled hormone
was about 11 nm.
To determine whether hormone re-
sponse varied with stages of culture
confluence, the adenylate cyclase response
was tested in membranes prepared from
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TABLE II. Characteristics of the Adenylate Cyclase Response to Salmon Calcitonin (SCT)
of BEN Cells at Various Times after Subculture. BEN Cells were Plated Out (3 x 105
Cells/Flask) on Day 0. At Various Times Subsequently, Cells were Harvested, Particulate
Preparations Obtained and the Adenylate Cyclase Response toSCTDetermined. *Maximum
Response Occurred in the Presence of 60 nM SCT. Values in Columns 2 and 3 are Means
+ s.e. from, 3 Determinations
DJay
,5
7
9
1 1
:13
15
Cyclic AMP (pm(l/mg protein/20 mi)
Basal MAlaximum*
5'6 2
72±1
48±1
53± 3
73 -5
66 6
1744-3
216± 1
126± 1
1494-2
191 4-8
177 t- 13
cultures at increasing time after sub-
culture up to the time ofconfluence, which
occurred at Day 15. Theresults (Table II)
show that no change in responsiveness
occurred. In view of the overall results of
this experiment, the single observation
(Day 11) of a possibly higher requirement
of SCT for half the maximum activation
of adenylate cyclase cannot be regarded as
significant.
In view of the possible implications of
the above observations, namely that a
calcitonin-producing tumour cell could
respond to its own apparent product, 2
further series of experiments were carried
out. In the first, salmon calcitonin was
applied to cultured cells for 4 h before the
cells were washed and assayed for calci-
tonin-responsive adenylate cyclase acti-
vity. Whereas membranes from control
cells responded as usual (Table III), those
pre-incubated with calcitonin were found
to be resistant to adenylate cyclase
activation by the hormone. In the second,
a sample of medullarv thyroid carcinoma
tissue was obtained at surgery from a
patient known to have high levels of
calcitonin. The adenylate cyclase re-
sponse of membranes from this tumour
was studied, and was found to be stimu-
lated only bv gluca,gon (Table IV).
Salmon calcitonin was ineffective in the
1agtge from 60 nM to 6 /IM.
SCT conceintration
(nm) for
AMaximum/basal half-maximal
ratio activation
3 1
3-0
2-6
2 -8
2-6
2 7
14- 1
13-5
18-0
48 0
18-6
15-0
TABLE III. Falcon Flasks of BEN Cells
were Incubatedfor 4 h in Control Medium
(2Flasks) andMedium Containing 150nM
SCT (2 Flasks). After Thorough Washing
of Cells, Particulate Preparations were
MadeandAssayedforBasalandHormone-
responsive Adenylate Cyclase. Values are
Mean ± s.e. of 3 Determinations
Aden-late cvYclase activity
Control
Basal
SCT 3 nMr
SCT 30 nw
SCT 300 nA
CT-AM 6 nwA
CT-AI 60 nwI
CT-M 600 niM
15.2jI 1
26 90 7
29-24- I-
3:3-2 2 1 -9
19-3 +I 3
24 2 I 0
26 8+0 05
(pmol cyclic
AMP/incubationi)
Pre-incubate(d 4 h
with SCT (150 we)
18-3±0 7
165-O0-8
17-6-40-4
18-5±O0- 7
17-8- 0-1
18-3--O 6
15-60 0-9
D)ISCUSSION
The BEN cell line has been known for
some time to produce CEA and calcitonin
(Ellison et al., 1975). The latter has been
measured by radioimmunoassay, and has
been shown recently to be secreted in a
form which is of higher molecular weight
than monomeric human calcitonin, al-
though mild trypsin treatment converts
it to the size of CT-M on gel filtration
(Coombes et al., 1977). The observation
that BEN cells also had a calcitonin-
responsive adenylate cyclase was a sur-
prising one, but the present evidence
Id-Si1782 N. H. HUNT, M. ELLISON, J. C. E. UNDERWOOD AND T. J. MARTIN
TABLE IV.-Effect ofHormones on Adenylate Cyclase Activity ofParticulate Preparations
from Human Medullary Thyroid Carcinoma. Tumour was Removed at Surgery from a
Patient with Elevated Plasma Calcitonin Levels. Within 1 h it was Homogenized in
25 mm Tris, pH 7.4, Centrifuged at 2200 g for 15 min, Resuspended and Assayed (see
Methods). Means + s.e. of 3 Determinations for Each Value. Prostaglandins E1, E2
and F2a were Also Tested, and were Without Effect in Concentrationsfrom 1-100,UM
Treatment
Control
Glucagon
Glucagon
Glucagon
Salmon calcitonin
Salmon calcitonin
Salmon calcitonin
Isoprenaline
Isoprenaline
Gastrin
Gastrin
Sodium fluoride
Concentration
60 nm
600 nM
6 Mm
60 nM
600 nM
6 Mm
6 Mm
60,uM
2 Mm
20 /am
10 mMI
confirms this in a number of ways. First,
the various calcitonins had relative poten-
cies in this system roughly paralleling
their potencies in others, e.g. rat kidney
and bone membranes (Marx, Woodard
and Aurbach, 1972); second, the intact
cells responded to hormone by an increase
in intracellular cyclic AMP; and, finally,
labelled calcitonin was found to bind to
particulate cell preparations, while bio-
logically active, unlabelled calcitonins
competed for binding.
Although specific calcitonin receptors
have been demonstrated in thymoma cell
lines (Marx et al., 1974), these were not
associated with any demonstrable cell
activation process. The BEN cells on the
other hand possess a receptor which is
probably concerned with the stimulation
of adenylate cyclase by calcitonin. It is
possible that the BEN cell population is
not homogeneous, and contains one sub-
population which secretes calcitonin and
one which has a calcitonin receptor.
However, homogeneity, as assessed by
morphological and functional (production
of CEA and calcitonin) criteria, has been
maintained over some 120 passages in 31
months (Ellison et al., 1975; Ellison,
unpub.). Alternatively, the cells might
secrete calcitonin at one stage of their
cycle and respond to it at another.
Synchronized cultures would be necessary
Adenylate cyclase activity
(pmol cyclic AMP/mg protein)
517±51
1154±65
1707± 282
2087± 155
630± 35
552± 50
573±6
868± 112
938± 60
525± 14
517±26
4609± 396
to exclude this possibility. Certain mouse
neuroblastoma cell lines may provide a
parallel for the observations reported here.
The cells respond to nerve growth factor
by increasing acetylcholinesterase produc-
tion (Goldstein, Brodeur and Ross, 1973)
and bind nerve growth factor at their
membranes (Revoltella et al., 1974). A
mouse neuroblastoma cell line also secretes
nerve growth factor (Murphy et al., 1975),
but the phenomena have not been studied
concurrently.
The possibility therefore remains that
the cells respond to their own hormonal
product. Earlier studies had indicated
that the BEN calcitonin was biologically
active in one in vitro system, since it
inhibited 45Ca release from mouse calvaria
maintained in culture (Ellison et al., 1975).
Subsequent assays of partially purified
media, however, have shown that the
calcitonin from BEN cells is ineffective in
lowering serum calcium in assay rats when
given at doses (20 ng calcitonin immuno-
assay equivalents) which should be effec-
tive (Coombes et al., 1977). Furthermore,
the results of the experiments ofTables II
and III favour the view that the calcitonin
of BEN medium is not biologically active,
because if it were it might be expected to
induce a state of permanent " desensitiza-
tion ", which would make it impossible to
detect a calcitonin-responsive adenylateCALCITONIN-RESPONSIVE ADENYLATE CYCLASE IN A CELL LINE 783
cyclase. This argument canniot be com-
pletely convincing, however, since it
remains possible that the rate of calcitonin
production (10 ng/confluent Falcon flask/
day) is insufficient to induce resistance.
Experiments to test this possibility are in
progress. Finally, since trypsinization can
convert BEN calcitonin to a form which
may be identical with CT-M (Coombes
et al., 1977), the biological activity seen in
bone culture may be explained by trypsin-
like activity in the bone culture system.
The secretion of calcitonin by BEN
cells is under a type of negative feedback
control, in that progressive dilution of
culture medium leads to a constant calci-
tonin concentration (Ellisonet al., 1976a,b).
This is similar to the feedback shown for
calcitonin release from medullary thyroid
cancer cells (Ellison et al., 1976b) and for
thyroid C cells (Orme and Pento, 1976).
The mechanism of this feedback is un-
known and may be unrelated to the
presence ofthe calcitonin receptor. Medul-
lary thyroid carcinoma does not appear to
possess calcitonin receptors linked to
adenylate cyclase (Table IV). It should
also be noted that in mammalian calci-
tonin-secreting cells, cyclic AMP stimu-
lates hormone production rather than
inhibits it (Bell and Queener, 1974;
Gautvik and Tashjian, 1974). The mecha-
nism could be different in BEN cells,
although certain other features of the
regulation ofcalcitonin secretion in culture
are similar to those observed in mam-
malian C cells in vitro (Ellison et al.,
1976a).
- Other possible autoregulatory roles for
the calcitonin receptor are in the control
ofcell proliferation by means ofcalcitonin-
induced changes in the cell's cyclic AMP,
and in the control of secretion of CEA,
also a product of BEN. N6-monobutyryl
cyclic AMP has been shown to enhance
CEA production and increase the mean
cell-doubling time in BEN cultures (Elli-
son et al., 1976b). If BEN calcitonin does
interact with calcitonin receptors on the
cells, however, it seems likely that adenyl-
ate cyclase response would change with
lengthening exposure to increasing hor-
mone concentrations, since regulation of
receptor numbers and affinities by hor-
mones has been reported in a number of
systems (Lesniak et al., 1974; Hinkle and
Tashjian, 1975; Mukherjee, Caron and
Lefkowitz; 1976), and is suggested by the
experiment described in Table III. Simi-
larly, adenylate cyclase response would
be expected to change with time after
subculture, if the enzyme were associated
with autoregulation. Table II shows,
however, that the characteristics of the
hormone-responsive adenylate cyclase did
not change between 5 days after sub-
culture and confluence (15 days).
Directstudiesoftheinteraction ofBEN
calcitonin with BEN receptors have not
been performed, because highly purified
preparations of the hormone are not
available. It is not possible at present to
decide what functional relationship exists
between the phenomena of human calci-
tonin production and responsiveness to
calcitonin in these cancer cells.
This work has been supported by a
grant from the Yorkshire Council of the
Cancer Research Campaign. We are
grateful to Professor A. M. Neville for
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